Industry News

Sep 25, 2018
By Pharmaceutical Technology Editors
Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Sep 25, 2018
By Pharmaceutical Technology Editors
Winners for each category will be revealed at the CPhI Pharma Awards Gala, taking place on Oct. 9, 2018.
Sep 24, 2018
By Pharmaceutical Technology Editors
FDA awarded nearly $3 million in grants for continuous manufacturing and other advanced manufacturing technologies as part of the agency’s efforts to ensure a robust and reliable supply of biological products.
Sep 24, 2018
By Pharmaceutical Technology Editors
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended 13 new medicines for approval, including three orphan drug candidates.
Sep 24, 2018
By Pharmaceutical Technology Editors
Experts suggest health care providers and policymakers proceed with caution when exposing patients to the digital pill.
Sep 21, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Research by Thermo Fisher Scientific and LumaCyte suggests that LumaCyte's Radiance instrument offers the ability to rapidly analyze viral vaccines to speed development and production and ensure their effectiveness.
Sep 17, 2018
By Pharmaceutical Technology Editors
In the second half of CPhI’s annual report, experts review industry trends and warn that trade and patent changes could increase healthcare cost by $100 billion over the next five years.
Sep 17, 2018
By Pharmaceutical Technology Editors
FDA sent a warning letter to Lernapharm (Loris) Inc. detailing the company’s lack of procedures to prevent microbiological contamination.
Sep 14, 2018
By Pharmaceutical Technology Editors
FDA testing has found an additional impurity, N-Nitrosodiethylamine, in the API valsartan.
Sep 14, 2018
By Pharmaceutical Technology Editors
Researchers at Vanderbilt University Medical Center have isolated the first human monoclonal antibodies (mAbs) that can neutralize norovirus, a virus that causes acute gastrointestinal (GI) illness.
native1_300x100
lorem ipsum